NCT06504147: A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery

Sponsor: Oncoinvent Solutions AS. Phase: PHASE2. Conditions: Peritoneal Carcinomatosis, Ovarian Cancer